Skip to main content
. Author manuscript; available in PMC: 2012 Jul 15.
Published in final edited form as: Int J Pharm. 2011 Apr 23;413(1-2):44–50. doi: 10.1016/j.ijpharm.2011.04.051

Fig. 6.

Fig. 6

Vivid assay for determining the CYP3A4 inhibitory potency: Concentration-response curve shows the % of CYP3A4 activity in presence of increasing concentrations (25µg/mL–1200µg/mL) of sutherlandia. Each data point represents mean ± S.D. (n = 7), (**) represents significant difference from control (p < 0.01).